These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8265732)

  • 1. [Basic and clinical study of senile dementia].
    Hirai S
    Seishin Shinkeigaku Zasshi; 1993; 95(9):693-701. PubMed ID: 8265732
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease. Tangle disentanglement.
    Beyreuther K; Masters CL
    Nature; 1996 Oct; 383(6600):476-7. PubMed ID: 8849716
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomedicine. Tauists and beta-aptists united--well almost!
    Lee VM
    Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
    Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
    Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent study on Alzheimer's disease].
    Hirai S
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):367-71. PubMed ID: 8315330
    [No Abstract]   [Full Text] [Related]  

  • 7. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of Alzheimer's disease and dementia.
    Bugiani O
    Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanisms in Alzheimer's disease].
    Coria F; Rubio I
    Rev Neurol; 1997 Jul; 25 Suppl 1():S50-4. PubMed ID: 9280667
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).
    Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S
    Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
    Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
    Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease. A new take on tau.
    Marx J
    Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
    [No Abstract]   [Full Text] [Related]  

  • 15. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
    Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
    Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation.
    Santa-María I; Hernández F; Moreno FJ; Avila J
    Neurosci Lett; 2007 Dec; 429(2-3):91-4. PubMed ID: 17976912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment.
    Herukka SK; Hallikainen M; Soininen H; Pirttilä T
    Neurology; 2005 Apr; 64(7):1294-7. PubMed ID: 15824371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2007 Feb; 113(2):107-17. PubMed ID: 17089134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.